Healthtech platform, Medikabazaar, declared that it had raised $75 million in its Series C funding led by Creagis and CDC Group. The existing investors, including Ackermans & van Haaren (AvH), HealthQuad Advisors Private Limited, Rebright Partners, Kois Holdings, and Sumitomo Mitsui Financial Group, also participated in the round. The funds will deepen the company’s digital capabilities, grow the supply ecosystem, technology-driven distribution channels and provide a more extensive range of quality medical supplies over geographical regions.

• Trade War May Ease if China Shifts Manufacturing to US: Jefferies
• 55th GST Council Set to Held on 21 December 
• C2C Advanced Systems IPO GMP Today, Lot Size, Issue Date & Financials
• India to Lead Global Economy and AI: John Chambers
• Nazara Tech and WTFund to Invest in Two Gaming Startups 

“We are thrilled to welcome Creagis and the CDC Group on board as investors. We are fascinated by the digital transformation track record of Creaegis and are trying to create a technology-driven platform assisting the healthcare ecosystem. The investment will let us improve our international operations and strengthen our presence in the B2B health tech industry,” Vivek Tiwari, Founder and Chief Executive Officer of Medikabazaar said. “With over 100,000 medical institutions, above 150,000 medical professionals, and over 15,000 seller partners, we are trying for a 300 per cent growth in FY22,” Tiwari added.